These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16543530)

  • 1. Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies.
    Candler PM; Dale RC; Griffin S; Church AJ; Wait R; Chapman MD; Keir G; Giovannoni G; Rees JH
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):507-12. PubMed ID: 16543530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neurofilament protein antibodies in opsoclonus-myoclonus.
    Noetzel MJ; Cawley LP; James VL; Minard BJ; Agrawal HC
    J Neuroimmunol; 1987 Jun; 15(2):137-45. PubMed ID: 3294894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.
    Dale RC; Candler PM; Church AJ; Wait R; Pocock JM; Giovannoni G
    J Neuroimmunol; 2006 Mar; 172(1-2):187-97. PubMed ID: 16356555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantigen diversity in the opsoclonus-myoclonus syndrome.
    Bataller L; Rosenfeld MR; Graus F; Vilchez JJ; Cheung NK; Dalmau J
    Ann Neurol; 2003 Mar; 53(3):347-53. PubMed ID: 12601702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues.
    Connolly AM; Pestronk A; Mehta S; Pranzatelli MR; Noetzel MJ
    J Pediatr; 1997 Jun; 130(6):878-84. PubMed ID: 9202608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome.
    Blaes F; Fühlhuber V; Korfei M; Tschernatsch M; Behnisch W; Rostasy K; Hero B; Kaps M; Preissner KT
    Ann Neurol; 2005 Aug; 58(2):313-7. PubMed ID: 15988749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
    Dalmau J; Porta-Etessam J
    Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-streptococcal auto-antibodies inhibit protein disulfide isomerase and are associated with insulin resistance.
    Aran A; Weiner K; Lin L; Finn LA; Greco MA; Peppard P; Young T; Ofran Y; Mignot E
    PLoS One; 2010 Sep; 5(9):e12875. PubMed ID: 20886095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome.
    Beck S; Fühlhuber V; Krasenbrink I; Tschernatsch M; Kneifel N; Kirsten A; Jaeger C; Kaps M; Preissner KT; Lang B; Rostasy K; Blaes F
    J Neuroimmunol; 2007 Apr; 185(1-2):145-9. PubMed ID: 17324472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult paraneoplastic opsoclonus-myoclonus syndrome associated with antimitochondrial autoantibodies.
    Blaes F; Jauss M; Kraus J; Oschmann P; Krasenbrink I; Kaps M; Teegen B
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1595-6. PubMed ID: 14617731
    [No Abstract]   [Full Text] [Related]  

  • 11. Paraneoplastic Neurological Syndromes: A Condition of Increasing Recognition.
    Seluk L; Kivity S
    Isr Med Assoc J; 2018 Oct; 20(10):649-650. PubMed ID: 30324785
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and regional expression of chicken neuroleukin (glucose-6-phosphate isomerase) messenger RNA.
    Hallböök F; Persson H; Barbany G; Ebendal T
    J Neurosci Res; 1989 Jun; 23(2):142-51. PubMed ID: 2754762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome.
    Korfei M; Fühlhuber V; Schmidt-Wöll T; Kaps M; Preissner KT; Blaes F
    J Neuroimmunol; 2005 Dec; 170(1-2):150-7. PubMed ID: 16203043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic neurological disorders.
    Blaes F; Tschernatsch M
    Expert Rev Neurother; 2010 Oct; 10(10):1559-68. PubMed ID: 20925471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-streptococcal antibodies are associated with metabolic syndrome in a population-based cohort.
    Aran A; Lin L; Finn LA; Weiner K; Peppard P; Young T; Mignot E
    PLoS One; 2011; 6(9):e25017. PubMed ID: 21949836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
    Braik T; Evans AT; Telfer M; McDunn S
    Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane antigens of oral Treponema species.
    Tall BD; Nauman RK
    J Med Microbiol; 1994 Jan; 40(1):62-9. PubMed ID: 8289216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome.
    Panzer JA; Anand R; Dalmau J; Lynch DR
    J Neuroimmunol; 2015 Sep; 286():86-92. PubMed ID: 26298330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opsoclonus myoclonus with ataxia].
    Asher I; Elbirt D; Kushnir M; Sthoeger ZM
    Harefuah; 2005 Mar; 144(3):163-7, 232. PubMed ID: 15844453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.